A Study to Evaluate the Efficacy and Safety of Combination of Erlotinib and Temozolomide with Radiation in Elderly Non Small Cell Lung Cancer Patients with Brain Metastases

Trial Profile

A Study to Evaluate the Efficacy and Safety of Combination of Erlotinib and Temozolomide with Radiation in Elderly Non Small Cell Lung Cancer Patients with Brain Metastases

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Dec 2015

At a glance

  • Drugs Erlotinib (Primary) ; Temozolomide (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 15 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top